Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus
This study is currently recruiting participants.
Verified April 2012 by ikfe-CRO GmbH
Sponsor:
Marcus Borchert
Collaborators:
ikfe-CRO GmbH
Boehringer Ingelheim Pharmaceuticals
Information provided by (Responsible Party):
Marcus Borchert, ikfe-CRO GmbH
ClinicalTrials.gov Identifier:
NCT01547104
First received: February 21, 2012
Last updated: April 10, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2012 |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |